One of the many aggressive and worst types of cancer is neuroendocrine carcinoma of colon. The worst thing about this is that it’s most frequently detected at the advanced stages at which time it is more difficult to curb it and treat it.
As the symptoms of neuroendocrine colon cancer become visible only in the most advanced stages the rate of survival of the patient diminishes. The tumors are always malignant, and mostly detected with distant metastases. Most recent surveys show that reports tell us that in almost all cases of neuroendocrine cancer end with the death of the patient.
Though the possibilities of neuroendocrine carcinoma in colon are rare at best if one is affected the patient’s heath becomes much worse than patients who suffer from adenocarcinoma.
Research reveals that the end results surrounding this form of cancer do not differ with age, sex or tumour location. Though neuroendocrine colon carcinoma depends on which stage the tumour is in Standard cases have revealed that people in stage 1 and 2 of cancer usually do not suffer from neuroendocrine colon cancer. But alternately in several cases, if said tumour is in stage 3 or 4, it is a laborious and hard task the neuroendocrine colon carcinoma.
Unfortunately, medical science has developed no adequate methods to deal with this particular cancer. A more common technique that doctors might use is immunohistochemical staining methods. This method assists doctors in dealing with the severity of the neuroendocrine colon cancer and helps to determine the most helpful medication and treatment for it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. It involves the staining of the tumor with a monoclonal antibody A-80 which will help in the identification of the quantum of neuroendocrine differentiation and nature of the damage on the health of the patient.
Neuroendocrine colon carcinoma is difficult to treat and in a certain study in which a number of patients suffered from this particular disease underwent examination and, it was noted that the overall survival rate for this disease was only about seven months. In the later stages these rates decrease, to as low as five months or less. The great majority of these cases were originally seen as carcinoids but they later developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer does not have a good prognosis and surgery is not always a perfect or even viable treatment so surgery may not provide a satisfactory cure. Therefore it becomes necessary to notice the presence of this disease quickly and prescribe the right medication.
To find out exactly how you can get Caltrate Colon Health info visit my Dukes C Colon Carcinoma website.